亚辉龙蹭脑机热点遭警示后又被立案 主业和“炒股”双失利归母净利预降90%

Core Viewpoint - YHLO (688575.SH) has transitioned from being a "market darling" to a subject of investigation for information disclosure violations within a month, following its announcement to enter the brain-computer interface sector [1][2]. Group 1: Regulatory Issues - YHLO was officially investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which was triggered by its announcement on January 6 regarding a strategic cooperation framework with Brain Machine Star Chain Technology Co., Ltd [1][4]. - The Shanghai Stock Exchange (SSE) had previously issued a warning to YHLO's then Secretary of the Board for discrepancies and incomplete information in its disclosures related to the cooperation announcement [2][3]. Group 2: Financial Performance - YHLO's financial performance is under pressure, with a forecasted net profit attributable to shareholders for 2025 expected to be between 20 million to 30 million yuan, representing a year-on-year decline of 90.05% to 93.37% [1][6]. - The company reported revenues of 39.81 billion yuan in 2022, which dropped to 20.53 billion yuan in 2023, and is projected to further decline to 20.12 billion yuan in 2024 [6]. - The decline in profitability is attributed to reduced market demand, losses from trading financial assets, and the need for asset impairment provisions [7]. Group 3: Market and Product Development - YHLO has been focusing on expanding its product offerings, with its domestic chemiluminescence product menu increasing to 180 items by the end of 2025 [8]. - Despite challenges in the domestic market, YHLO's international marketing business has shown stable growth, with ongoing efforts in regional coverage and local service [7].